Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: A shotgun lipidomics study

Journal of Neurochemistry

Volumn 101, Issue 1, 2007, Pages 57-76

  Cheng, Hua ^a   Jiang, Xuntian ^a   Han, Xianlin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Dorsal root ganglion; Electrospray ionization mass spectrometry; Lipidomics; Peripheral nervous system; Shotgun lipidomics; Sphingolipid metabolism; Sulfatide

Indexed keywords

APOLIPOPROTEIN E; CERAMIDE; GALACTOSYLCERAMIDE; LIPID; SULFATIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTECHNOLOGY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHOLESTEROL METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; HOMEOSTASIS; HYPERLIPOPROTEINEMIA TYPE 3; KNOCKOUT MOUSE; LIPID ANALYSIS; LIPID METABOLISM; LIPID TRANSPORT; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; NULL ALLELE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SPINAL GANGLION; STATISTICAL SIGNIFICANCE;

ANIMALS; APOLIPOPROTEINS E; CELLS, CULTURED; CERAMIDES; CHOLESTEROL; GALACTOSYLCERAMIDES; GANGLIA, SPINAL; HOMEOSTASIS; LIPID METABOLISM; LIPIDS; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NECK; NEURONS, AFFERENT; PERIPHERAL NERVOUS SYSTEM DISEASES; SULFOGLYCOSPHINGOLIPIDS; TRIGLYCERIDES;

MUS;

EID: 33947261547     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04342.x     Document Type: Article

References (69)

1. Bales K. R., Dodart J. C., Demattos R. B., Holtzman D. M. and Paul S. M. (2002) Apolipoprotein E, amyloid, and Alzheimer disease. Mol. Interv. 2, 363-375, 379.
2. Bligh E. G. and Dyer W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
3. Boumann H. A., Damen M. J. A., Versluis C., Heck A. J. R., De Kruijff B. and De Kroon A. I. P. M. (2003) The two biosynthetic routes leading to phosphatidylcholine in yeast produce different sets of molecular species. Evidence for lipid remodeling. Biochemistry 42, 3054-3059.
4. Boumann H. A., Chin P. T. K., Heck A. J. R., De Kruijff B. and De Kroon A. I. P. M. (2004) The yeast phospholipid N-methyltransferases catalyzing the synthesis of phosphatidylcholine preferentially convert di-C16:1 substrates both in vivo and in vitro. J. Biol. Chem. 279, 40 314-40 319.
5. Boyles J. K., Notterpek L. M. and Anderson L. J. (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J. Biol. Chem. 265, 17 805-17 815.
6. Cheng H., Xu J., Mckeel D. W. Jr and Han X. (2003) Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study. Cell. Mol. Biol. 49, 809-818.
7. Cheng H., Guan S. and Han X. (2006) Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy. J. Neurochem. 97, 1288-1300.
8. Delong C. J., Shen Y.-J., Thomas M. J. and Cui Z. (1999) Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J. Biol. Chem. 274, 29 683-29 688.
9. Demattos R. B., Brendza R. P., Heuser J. E., Kierson M., Cirrito J. R., Fryer J., Sullivan P. M., Fagan A. M., Han X. and Holtzman D. M. (2001) Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39, 415-425.
10. Elshourbagy N. A., Liao W. S., Mahley R. W. and Taylor J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl Acad. Sci. USA 82, 203-207.
11. Finck B. N., Lehman J. J., Leone T. C. et al. (2002) The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109, 121-130.
12. Finck B. N., Han X., Courtois M., Aimond F., Nerbonne J. M., Kovacs A., Gross R. W. and Kelly D. P. (2003) A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl Acad. Sci. USA 100, 1226-1231.
13. Fressinaud C., Rigaud M. and Vallat J. M. (1986) Fatty acid composition of endoneurium and perineurium from adult rat sciatic nerve. J. Neurochem. 46, 1549-1554.
14. Fressinaud C., Vallat J. M., Rigaud M. and Leboutet M. J. (1987a) Analysis of unsaturated fatty acids of endoneurium and perineurium from normal and degenerating rat sciatic nerve. Morphological correlations. J. Neurol. Sci. 81, 85-92.
15. Fressinaud C., Vallat J. M., Durand J., Archambeaud-Mouveroux F. and Rigaud M. (1987b) Changes in composition of endoneurial and perineurial fatty acids during glycerol-induced Wallerian degeneration and regeneration in the sciatic nerve of the adult rat. J. Neurochem. 49, 797-801.
16. Fullerton S. M., Strittmatter W. J. and Matthew W. D. (1998) Peripheral sensory nerve defects in apolipoprotein E knockout mice. Exp. Neurol. 153, 156-163.
17. Fullerton S. M., Shirman G. A., Strittmatter W. J. and Matthew W. D. (2001) Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice. Exp. Neurol. 169, 13-22.
18. Ganser A. L., Kerner A. L., Brown B. J., Davisson M. T. and Kirschner D. A. (1988) A survey of neurological mutant mice. I. Lipid composition of myelinated tissue in known myelin mutants. Dev. Neurosci. 10, 99-122.
19. Griffiths W. J. (2003) Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids. Mass Spectrom. Rev. 22, 81-152.
20. Hamilton L., Greiner R., Salem N. Jr and Kim H. Y. (2000) n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids 35, 863-869.
21. Han X. (2004) The role of apolipoprotein E in lipid metabolism in the central nervous system. Cell. Mol. Life Sci. 61, 1896-1906.
22. Han X. and Cheng H. (2005) Characterization and direct quantitation of cerebroside molecular species from lipid extracts by shotgun lipidomics. J. Lipid Res. 46, 163-175.
23. Han X. and Gross R. W. (1990) Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs. Biochemistry 29, 4992-4996.
24. Han X. and Gross R. W. (2001) Quantitative analysis and molecular species fingerprinting of triacylglyceride molecular species directly from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal. Biochem. 295, 88-100.
25. Han X. and Gross R. W. (2003) Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44, 1071-1079.
26. Han X. and Gross R. W. (2005a) Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of the cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24, 367-412.
27. Han X. and Gross R. W. (2005b) Shotgun lipidomics: multi-dimensional mass spectrometric analysis of cellular lipidomes. Expert Rev. Proteomics 2, 253-264.
28. Han X., Holtzman D. M. and Mckeel D. W. Jr (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168-1180.
29. Han X., Holtzman D. M., Mckeel D. W. Jr, Kelley J. and Morris J. C. (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82, 809-818.
30. Han X., Cheng H., Fryer J. D., Fagan A. M. and Holtzman D. M. (2003a) Novel role for apolipoprotein E in the central nervous system: modulation of sulfatide content. J. Biol. Chem. 278, 8043-8051.
31. Han X., Fagan A. M., Cheng H., Morris J. C., Xiong C. and Holtzman D. M. (2003b) Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann. Neurol. 54, 115-119.
32. Han X., Cheng H., Mancuso D. J. and Gross R. W. (2004a) Caloric restriction results in phospholipid depletion, membrane remodeling and triacylglycerol accumulation in murine myocardium. Biochemistry 43, 15 584-15 594.
33. Han X., Yang J., Cheng H., Ye H. and Gross R. W. (2004b) Towards fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal. Biochem. 330, 317-331.
34. Han X., Yang K., Cheng H., Fikes K. N. and Gross R. W. (2005a) Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatization. J. Lipid Res. 46, 1548-1560.
35. Han X., Yang J., Cheng H., Yang K., Abendschein D. R. and Gross R. W. (2005b) Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44, 16 684-16 694.
36. Han X., Yang K., Yang J., Fikes K. N., Cheng H. and Gross R.W. (2006) Factors influencing the electrospray intrasource separation and selective ionization of glycerophospholipids. J. Am. Soc. Mass Spectrom. 17, 264-274.
37. Horsburgh K., Mccarron M. O., White F. and Nicoll J. A. (2000) The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol. Aging 21, 245-255.
38. Jungalwala F. B., Evans J. E. and Mccluer R. H. (1984) Compositional and molecular species analysis of phospholipids by high performance liquid chromatography coupled with chemical ionization mass spectrometry. J. Lipid Res. 25, 738-749.
39. Kevala J. H. and Kim H. Y. (2001) Determination of substrate preference in phosphatidylserine decarboxylation by liquid chromatography-electrospray ionization mass spectrometry. Anal. Biochem. 292, 130-138.
40. Koch S., Donarski N., Goetze K., Kreckel M., Stuerenburg H. J., Buhmann C. and Beisiegel U. (2001) Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 42, 1143-1151.
41. Kypreos K. E., Van Dijk K. W., Van Der Zee A., Havekes L. M. and Zannis V. I. (2001) Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo: carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion. J. Biol. Chem. 276, 19 778-19 786.
42. Lagarde M., Geloen A., Record M., Vance D. and Spener F. (2003) Lipidomics is emerging. Biochim. Biophys. Acta 1634, 61.
43. Larsen A., Mokastet E., Lundanes E. and Hvattum E. (2002) Separation and identification of phosphatidylserine molecular species using reversed-phase high-performance liquid chromatography with evaporative light scattering and mass spectrometric detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 774, 115-120.
44. Laws S. M., Hone E., Gandy S. and Martins R. N. (2003) Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem. 84, 1215-1236.
45. Lin C. T., Xu Y. F., Wu J. Y. and Chan L. (1986) Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues. J. Clin. Invest. 78, 947-958.
46. Linington C., Neuhoff V. and Waehneldt T. V. (1980) The lipid and glycoprotein composition of peripheral-nervous-system myelin subfractions isolated by zonal centrifugation. Biochem. Soc. Trans. 8, 69-70.
47. Listenberger L. L., Han X., Lewis S. E., Cases S., Farese R. V. Jr, Ory D. S. and Schaffer J. E. (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl Acad. Sci. USA 100, 3077-3082.
48. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
49. Mahley R. W. and Rall S. C. Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1, 507-537.
50. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I. and Roses A. D. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136, 107-122.
51. Mensenkamp A. R., Van Luyn M. J. A., Havinga R. et al. (2004) The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice. J. Hepatol. 40, 599-606.
52. Merrill A. H. Jr, Sullards M. C., Allegood J. C., Kelly S. and Wang E. (2005) Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36, 207-224.
53. Moser H. W. (1995) Farber lipogranulomatosis, in The Metabolic and Molecular Bases of Inherited Diseases, 7th edn (Scriver C. R., Beaudet A. L., Sly W. S. and Valle D., eds), pp. 2589-2599. McGraw-Hill, New York.
54. Pepeu G., Pepeu I. M. and Amaducci L. (1996) A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the aging brain? Pharmacol. Res. 33, 73-80.
55. Poirier J., Baccichet A., Dea D. and Gauthier S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90.
56. Pola R., Gaetani E., Flex A., Aprahamian T., Proia Anna S., Bosch-Marce M., Smith Roy C. and Pola P. (2003) Peripheral nerve ischemia: apolipoprotein E deficiency results in impaired functional recovery and reduction of associated intraneural angiogenic response. Exp. Neurol. 184, 264-273.
57. Posse De Chaves E. I., Vance D. E., Campenot R. B., Kiss R. S. and Vance J. E. (2000) Uptake of lipoproteins for axonal growth of sympathetic neurons. J. Biol. Chem. 275, 19 883-19 890.
58. Pulfer M. and Murphy R. C. (2003) Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22, 332-364.
59. Sawai H., Domae N. and Okazaki T. (2005) Current status and perspectives in ceramide-targeting molecular medicine. Curr. Pharm. Des. 11, 2479-2487.
60. Strittmatter W. J. and Roses A. D. (1996) Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19, 53-77.
61. Su X., Han X., Yang J., Mancuso D. J., Chen J., Bickel P. E. and Gross R. W. (2004) Sequential ordered fatty acid α oxidation and Δ9 desaturation are major determinants of lipid storage and utilization in differentiating adipocytes. Biochemistry 43, 5033-5044.
62. Suzuki K., Suzuki Y. and Suzuki K. (1995) Galactosylceramide lipidosis: globoid-cell leukodystrophy (Krabbe disease), in The Metabolic and Molecular Bases of Inherited Diseases, 7th edn (Scriver C. R., Beaudet A. L., Sly W. S. and Valle D., eds), pp. 2671-2692. McGraw-Hill, New York.
63. Unger R. H. (2002) Lipotoxic diseases. Annu. Rev. Med. 53, 319-336.
64. Von Figura K., Gieselmann V. and Jaeken J. (2001) Metachromatic leukodystrophy: lysosomal disorders, in The Metabolic and Molecular Bases of Inherited Diseases, 8th edn (Sachdev H. S., Beaudet A. L., Sly W. S. and Valle D., eds), pp. 3695-3724. McGraw-Hill, New York.
65. Weisgraber K. H., Roses A. D. and Strittmatter W. J. (1994) The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidol. 5, 110-116.
66. Welti R. and Wang X. (2004) Lipid species profiling: a high-throughput approach to identify lipid compositional changes and determine the function of genes involved in lipid metabolism and signaling. Curr. Opin. Plant Biol. 7, 337-344.
67. Wen Z. and Kim H. Y. (2004) Alterations in hippocampal phospholipid profile by prenatal exposure to ethanol. J. Neurochem. 89, 1368-1377.
68. Wenk M. R. (2005) The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594-610.
69. Yao J. K., Dyck P. J., Vanloon J. A. and Moyer T. P. (1981) Free fatty acid composition of human and rat peripheral nerve. J. Neurochem. 36, 1211-1218.